Literature DB >> 6888626

Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.

F Gejyo, B K Kishore, M Arakawa.   

Abstract

To elucidate the nature of the iminoacidopathy in uremia, the prolidase and prolinase activities in erythrocytes from 36 normal subjects, 28 patients with chronic uremia, and 21 patients on maintenance hemodialysis were determined. A statistically significant decrease in the activities of both prolidase and prolinase was found in the uremic patients and the hemodialysis group. No difference has been observed in the enzyme activities in the pre- and postdialysis samples of the hemodialysis patients. It is suggested that decreased activities of prolidase and prolinase may contribute to the iminoacidopathy in uremia, including high contents of serum iminoacid containing peptides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6888626     DOI: 10.1159/000183046

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.

Authors:  S Tabur; H Korkmaz; M Özkaya; U Elboğa; M Tarakçıoglu; N Aksoy; E Akarsu
Journal:  Tumour Biol       Date:  2015-04-29

3.  Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy.

Authors:  Refah Sayın; Mehmet Aslan; Mehmet Emin Kucukoglu; Arda Luleci; Murat Atmaca; Ramazan Esen; Halit Demir
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

4.  The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.

Authors:  Tevfik Sabuncu; Omer Boduroglu; Mehmet Ali Eren; Ayse Nur Torun; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

5.  Serum prolidase activity is associated with non-diabetic metabolic syndrome.

Authors:  Suzan Tabur; Elif Oguz; Mehmet Ali Eren; Hakan Korkmaz; Esen Savas; Nurten Aksoy; Tevfik Sabuncu
Journal:  Diabetol Metab Syndr       Date:  2014-12-17       Impact factor: 3.320

6.  Circulating Prolidase Activity in Patients with Myocardial Infarction.

Authors:  Adnan Sultan; Yuting Zheng; Patrick J Trainor; Yong Siow; Alok R Amraotkar; Bradford G Hill; Andrew P DeFilippis
Journal:  Front Cardiovasc Med       Date:  2017-07-31

7.  Evaluation of serum prolidase activity in patients with slow coronary flow.

Authors:  Arif Suner; Abdullah Nurdag; Mustafa Polat; Hakan Kaya; Sedat Koroglu; Gurkan Acar; Hatice Sezen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.